Category: Drug Recall Notices
-
Constipation Medication Zelnorm Linked To Apparent Increased Risk Of Heart Attacks And Strokes
Novartis Suspends Sales After FDA Determines That Risks Of Serious Side Effects Outweigh Benefits Of Zelnorm (Posted by Tom Lamb at DrugInjuryWatch.com) On March 30, 2007 the FDA announced that Novartis Pharmaceuticals Corporation had…
-
Bristol-Myers Squibb To Stop Selling Antibiotic Drug Tequin
BMS Action Follows Reports Of Serious Blood-Sugar Problems And Recent Warning Label Changes An April 27, 2006 article by Peter Loftus for Dow Jones Newswires broke the news that Bristol-Myers Squibb Co. has decided…
-
December 2005 FDA “Patient Safety News” Videos For Doctors Online
Edition Covers Paxil, Strattera, Menactra Meningococcal Vaccine, and More The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily for doctors and other health care professionals. Generally, this…
-
Biogen Idec and Elan Want to Resume Selling Their MS Drug Tysabri in the U.S.
Tysabri Recalled From the Market in Early 2005 Due to PML, a Fatal Brain Condition Biogen Idec Inc. and Elan Corp., the makers of the multiple sclerosis ("MS") drug Tysabri, filed papers with the…
-
Analyst Report Forecasts Some Choppy Waters for Return of Tysabri
FDA Adverse Event Reports Show Tysabri May Be Tied To Other Serious Side Effects On August 29, 2005 The Wall Street Journal ("WSJ") reported that a list of adverse event reports made to the…
-
Tysabri: Will this Multiple Sclerosis Drug Return to U.S. Market or Not?
Fourth Case of Tysabri-related PML is Reported to FDA by Manufacturer A fourth patient taking the multiple sclerosis drug Tysabri may have contracted a deadly brain disease called progressive multifocal leukoencephalopathy, or PML, calling…
-
FDA Announces Recall of All Drugs from Able Laboratories
All Able Laboratories Drugs Recalled Due to Production Quality Concerns On June 1, 2005 the FDA announced that the agency has issued a nationwide recall of all drugs — mostly generic prescription drugs, including…
-
Recalled Drug Bextra Might Return to U.S. Market
FDA Had Pfizer Pull Bextra Because of Serious Skin Reaction Side Effects Pfizer Inc. wants its arthritis drug Bextra returned to the U.S. market and plans to discuss with the FDA how it might…